Clinical trials for Liver and bile duct cancer

134 currently recruiting clinical trials
Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT03767075 #2024-514238-19-00
Module 2 bras 2B, Module 3 bras 3A et 3C
Locally Advanced Metastatic Metastatic Castration-resistant EGFR FGFR MET 1 2 3 or more
Systemic Treatment-Naive
1 recruiting site
Institut d'oncologie du Vall d'Hebron
Phase 2 Liver and bile duct cancer #NCT07036380 #2024-520029-35-00
Intrahepatic cholangiocarcinoma Extrahepatic cholangiocarcinoma Locally Advanced Metastatic None Systemic Treatment-Naive
Immunotherapy
9 recruiting sites
Centre Hospitalier Universitaire de Besancon
Phase 2 Liver and bile duct cancer #NCT06218420
Hepatocellular carcinoma Localized Unhealthy A B None
2 recruiting sites
Assistance Publique - Hôpitaux de Paris
Phase 2 Liver and bile duct cancer #NCT07128290 #2025-521302-17-00
Intrahepatic cholangiocarcinoma Localized None Systemic Treatment-Naive
Surgery Radiofrequency ablation Transplant
1 recruiting site
Fédération Francophone de Cancérologie Digestive
Phase 2 Liver and bile duct cancer #NCT06904170 #2024-514912-28-00
Hepatocellular carcinoma Unhealthy A None Systemic Treatment-Naive Systemic Treatment-Naive
Transarterial chemoembolization
5 recruiting sites
UNICANCER
Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT06653777 #2024-512729-10-00
Locally Advanced Metastatic Metastatic Castration-resistant FGFR 1 2 3 or more
Systemic Treatment-Naive
6 recruiting sites
UNICANCER
Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT04116541 #2023-510567-35-00
Locally Advanced Metastatic Metastatic Castration-resistant Other mutation 1 2 3 or more
Systemic Treatment-Naive
7 recruiting sites
Centre Léon Bérard
Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT04116541 #2023-510567-35-00
Locally Advanced Metastatic Metastatic Castration-resistant BRAF 1 2 3 or more
Systemic Treatment-Naive
7 recruiting sites
Centre Léon Bérard
Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT04116541 #2023-510567-35-00
Locally Advanced Metastatic Metastatic Castration-resistant ALK 1 2 3 or more
Systemic Treatment-Naive
7 recruiting sites
Centre Léon Bérard
Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer #NCT04116541 #2023-510567-35-00
Locally Advanced Metastatic Metastatic Castration-resistant EGFR MET NTRK-1/2/3 RET ROS-1 Other mutation 1 2 3 or more
Systemic Treatment-Naive
7 recruiting sites
Centre Léon Bérard